Next Article in Journal
Recent Advances in the Synthesis of Selenophenes and Their Derivatives
Next Article in Special Issue
Larvicidal Activity of Cinnamic Acid Derivatives: Investigating Alternative Products for Aedes aegypti L. Control
Previous Article in Journal
An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 Subunit
Previous Article in Special Issue
Antibacterial Mode of Action of the Daucus carota Essential Oil Active Compounds against Campylobacter jejuni and Efflux-Mediated Drug Resistance in Gram-Negative Bacteria
 
 
Review

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction

1
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
2
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
3
Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA
4
Division of Hepatology, Department of Internal Medicine, Sandra Atlas Bass Center for Liver Diseases and Transplantation, Barbara and Zucker School of Medicine, Northwell Health, Manhasset, NY 11030, USA
5
Department of Surgery, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Simone Carradori
Molecules 2020, 25(24), 5905; https://doi.org/10.3390/molecules25245905
Received: 2 November 2020 / Revised: 5 December 2020 / Accepted: 9 December 2020 / Published: 13 December 2020
COVID-19 is known as one of the deadliest pandemics of the century. The rapid spread of this deadly virus at incredible speed has stunned the planet and poses a challenge to global scientific and medical communities. Patients with COVID-19 are at an increased risk of co-morbidities associated with liver dysfunction and injury. Moreover, hepatotoxicity induced by antiviral therapy is gaining importance and is an area of great concern. Currently, alternatives therapies are being sought to mitigate hepatic damage, and there has been growing interest in the research on bioactive phytochemical agents (nutraceuticals) due to their versatility in health benefits reported in various epidemiological studies. Therefore, this review provides information and summarizes the juncture of antiviral, immunomodulatory, and hepatoprotective nutraceuticals that can be useful during the management of COVID-19. View Full-Text
Keywords: COVID-19; coronavirus; ACE2; hepatic dysfunctions; hepatoprotective agents; nutraceuticals; SARS-CoV-2 COVID-19; coronavirus; ACE2; hepatic dysfunctions; hepatoprotective agents; nutraceuticals; SARS-CoV-2
Show Figures

Figure 1

MDPI and ACS Style

Sikander, M.; Malik, S.; Rodriguez, A.; Yallapu, M.M.; Narula, A.S.; Satapathy, S.K.; Dhevan, V.; Chauhan, S.C.; Jaggi, M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 2020, 25, 5905. https://doi.org/10.3390/molecules25245905

AMA Style

Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules. 2020; 25(24):5905. https://doi.org/10.3390/molecules25245905

Chicago/Turabian Style

Sikander, Mohammed, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, Vijian Dhevan, Subhash C. Chauhan, and Meena Jaggi. 2020. "Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction" Molecules 25, no. 24: 5905. https://doi.org/10.3390/molecules25245905

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop